837327.fig.002
Figure 2: (a) Schematic representation of functionalization of SWNTs with quantum dots, EDC, and cisplatin; (b) SWNT bioconjugated with cisplatin and EGF, targeting cancer cell surface receptor EGFR; (c)–(e) TEM images showing the various functional groups, with cisplatin shown as bright spots [7].